Table 2.
Barrier stressor; Clinical scenario | Specific Study | Effects on Barrier Function | Dietary Intervention and Its Effects | Reference # | |
---|---|---|---|---|---|
Intestinal permeability | Mucosal Damage | ||||
Endurance exercise Marathon runners with fecal occult blood or bloody diarrhea | Biking challenge | Urine iohexol (MW 821Da) ↑ | Serum I-FABP ↑, zonulin ↓ | 70 | |
Running challenge | LRR ↑ and correlated with core temperature (e.g. >39°C) | ND | 71 | ||
Biking challenge | LRR ↑ | Serum I-FABP ↑ | Citrulline (vs alanine) reversed ↑serum I-FABP and gastric hypoperfusion without effect on LRR | 72 | |
Biking challenge | ND | Serum I-FABP ↑ | Sucrose (vs. nitrate) reversed ↑ serum I-FABP no Δ gastric hypoperfusion | 73 | |
7 runners, 2 boxers, 3 rugby | LRR ↑ | ND | Nurticeutical colostrum vs. placebo reduced LRR ↑ and apoptosis of cell lines in vitro | 74 | |
NSAID enteropathy: NSAIDs cause small bowel ulcers and inflammation | Diverse NSAIDs e.g. indomethacin | 51CrEDTA, saccharides | ND | 75–77 | |
Indomethacin | LRR ↑ | ND | Zinc carnosine (vs. placebo) reduced LRR and increased HT29 cell proliferation (vs. ZnSO4) | 78 | |
Aspirin | increased colon permeability: urine SLR and sucralose | ND | Bifidobacterium BB-12 and adolescentis (IVS-1) and galacto-oligosaccharide prebiotic reduce colon permeability | 79 | |
Pregnancy with or without obesity | Increased serum zonulin and increased serum LPS, associated with metabolic risk markers | ND | 80 | ||
High serum zonulin | ND | n-3 PUFAs, fiber, and a range of vitamins and minerals: reduced high serum zonulin; greater richness of gut microbiota | 81 | ||
No effects on serum zonulin or LPS | ND | Probiotics and/or LC-PUFA | 82 |
Da=dalton; I-FABP=intestinal fatty-acid binding protein; LC-PUFA=long chain polyunsaturated fatty acids; LPS=lipopolysaccharide; LRR=lactulose-rhamnose ratio; ND=not determined; NSAIDs=nonsteroidal anti-inflammatory drugs; PUFA=polyunsaturated fatty acids; SLR=sucralose to lactulose ratio